Digital medicines, also known as digital therapeutics, are technology-based solutions that are designed to improve patient outcomes and optimize care delivery. These solutions use digital tools, such as mobile applications, wearable devices, and telemedicine, to help patients manage their health and wellness.
Digital medicines offer a range of benefits, including improved access to care, increased engagement, and better outcomes. Examples of digital medicines include mobile apps that help people manage chronic conditions, such as diabetes and heart disease, and wearable devices that track activity and monitor vital signs.
Digital medicines are seen as an important component of the future of healthcare and are increasingly being adopted by healthcare providers and payers as a way to enhance care delivery and improve patient outcomes.
Request a Sample Copy of the Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2749
Major players functioning in the digital medicines are i2Morrow Inc., Akili Interactive Labs, Ginger.io Inc., Livongo Health, WellDoc Inc., AliveCor Inc., Proteus Digital Health Inc., and Mocacare.
Digital Medicines Dynamics:
Digital medicines refer to the integration of digital technologies into the development, delivery, and use of medicines. This dynamic is transforming the traditional drug development process, as well as the way patients interact with their medications. Some of the key trends in this dynamic include:
· Remote Clinical Trials: Digital technologies are making it possible to conduct clinical trials in a more efficient and cost-effective manner. This includes remote monitoring of patients and the use of digital tools to collect data and manage study information.
· Personalized Medicine: The use of digital tools and technologies is helping to bring personalized medicine to the forefront, allowing for individualized dosing and treatment plans based on a patient's specific health needs and data.
· Telemedicine: The growth of telemedicine is allowing for remote consultation and treatment, enabling patients to receive care from the comfort of their own homes.
· Digital Therapeutics: The development of digital therapeutics is providing new options for patients with chronic diseases, including mental health conditions and neurological disorders.
· AI and Machine Learning: Artificial intelligence and machine learning are being used to develop predictive algorithms, which can be used to analyze patient data to determine the most effective treatment plans and improve outcomes.
The digital medicine market is segmented on the basis of technology, application and region.
By Technology
- Mobile Health
- Telehealth
- Wireless Health
- EMR/HER
By Application
- Diabetes
- Asthma
- Heart Disease
- Obesity
- COPD
- Smoking
- Drug Non Adherence
- Mental Health
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame
CA 94010, United States
Email: [email protected]
Phone: U.S.: +1-206-701-6702
U.K.: +44-020-8133-4027
